Patheon - Contract Pharmaceutical Development, Clinical Trial and Commercial Manufacturing Services

Patheon is a leading global provider of contract development and manufacturing services to the pharmaceutical industry. Patheon prides itself on providing the highest quality products and services to more than 300 pharmaceutical and biotechnology companies. Patheon’s services range from preclinical development through to the commercial manufacturing of a wide array of dosage forms, including parenteral, solid, semi-solid and liquids.

Integrated pharmaceutical development

Patheon’s comprehensive range of fully integrated pharmaceutical development services includes pre-formulation, formulation, analytical development, clinical supplies, scale-up and commercialization. Patheon’s ability to integrate development and manufacturing services ensures that our customers’ projects are delivered on time and meet the high standards of quality that Patheon is known for.

Patheon’s integrated development and manufacturing network of ten facilities and seven development centers, across North America and Europe, strives to ensure that customer products can be launched confidently and in a timely manner anywhere in the world.

Commercial pharmaceutical manufacturing services

Patheon’s commercial manufacturing for dosage capabilities include:

• Solids in tablets, capsules and powders
• Liquids and semi-solids capabilities
• Sterile products capabilities
• Lyophilization capabilities
• High potency capabilities
• Controlled substances capabilities
• Cephalosporin capabilities and lyophilization
• Solutions, suspensions, sprays and gels
• Liquid filled hard capsules
• Cytotoxics

Patheon also offers commercial manufacturing for specialized services, including Quick to Market™, restructuring services and small-scale commercial manufacturing.

Accelerated pharmaceutical development and product transfer

Quick to Market is a unique Patheon-only program that offers accelerated transfer of commercially available products from an existing manufacturing plant to a plant within Patheon’s network. The program was formally established as a service within Patheon after excellent results and significant client satisfaction with recent rapid product transfers.

Pharmaceutical development services

Patheon offers a range of pharmaceutical development services, including pre-formulation, analytical methods, scale up and validation, biopharmaceutical services, product registration and tech transfer.

Specialized development services include unique dosage forms, Quick to Clinic™, strategic alliances and clinical supplies.

Accelerated delivery of Phase I clinical trail materials

The Quick to Clinic program is designed for rapid distribution of clinical trial materials for first time in human (Phase I) studies. Utilizing Patheon’s Milton Park (UK) and Whitby (Canada) facilities, the Quick to Clinic program ensures delivery of finished drug product within four months from receipt of API. These designated delivery centers, specifically designed for early phase development, will provide a responsive and flexible service to our customers who are under pressure to screen product ideas and make proof of concept decisions quickly.

Clinical supplies

As part of its clinical supplies capabilities, Patheon offers primary and secondary clinical supplies packaging, blinded and multi-language labeling, storage, global distribution, returns, reconciliation and destruction.